These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

241 related items for PubMed ID: 33862110

  • 1. Roles of microRNAs in renal disorders related to primary podocyte dysfunction.
    Iranzad R, Motavalli R, Ghassabi A, Pourakbari R, Etemadi J, Yousefi M.
    Life Sci; 2021 Jul 15; 277():119463. PubMed ID: 33862110
    [Abstract] [Full Text] [Related]

  • 2. Renal microRNA- and RNA-profiles in progressive chronic kidney disease.
    Rudnicki M, Perco P, D Haene B, Leierer J, Heinzel A, Mühlberger I, Schweibert N, Sunzenauer J, Regele H, Kronbichler A, Mestdagh P, Vandesompele J, Mayer B, Mayer G.
    Eur J Clin Invest; 2016 Mar 15; 46(3):213-26. PubMed ID: 26707063
    [Abstract] [Full Text] [Related]

  • 3. The role of B7-1 in proteinuria of glomerular origin.
    Novelli R, Benigni A, Remuzzi G.
    Nat Rev Nephrol; 2018 Sep 15; 14(9):589-596. PubMed ID: 29959373
    [Abstract] [Full Text] [Related]

  • 4. [Expression of neonatal Fc receptor on human nephritis and rat nephritis models].
    Feng ST, Gan HL, Sun JY, Jiang T, Liu BL, Zhao ZH, Guo MY, Zhang ZG.
    Zhonghua Bing Li Xue Za Zhi; 2012 Feb 15; 41(2):81-5. PubMed ID: 22455882
    [Abstract] [Full Text] [Related]

  • 5. miR-217 Is a Useful Diagnostic Biomarker and Regulates Human Podocyte Cells Apoptosis via Targeting TNFSF11 in Membranous Nephropathy.
    Li J, Liu B, Xue H, Zhou QQ, Peng L.
    Biomed Res Int; 2017 Feb 15; 2017():2168767. PubMed ID: 29214160
    [Abstract] [Full Text] [Related]

  • 6. Inhibitory smads and tgf-Beta signaling in glomerular cells.
    Schiffer M, Schiffer LE, Gupta A, Shaw AS, Roberts IS, Mundel P, Böttinger EP.
    J Am Soc Nephrol; 2002 Nov 15; 13(11):2657-66. PubMed ID: 12397035
    [Abstract] [Full Text] [Related]

  • 7. Fra-2 is a novel candidate drug target expressed in the podocytes of lupus nephritis.
    Xu C, Miao Y, Pi Q, Zhu S, Li F.
    Clin Immunol; 2018 Dec 15; 197():179-185. PubMed ID: 30296590
    [Abstract] [Full Text] [Related]

  • 8. Assessment of urinary angiotensinogen as a marker of podocyte injury in proteinuric nephropathies.
    Eriguchi M, Yotsueda R, Torisu K, Kawai Y, Hasegawa S, Tanaka S, Noguchi H, Masutani K, Kitazono T, Tsuruya K.
    Am J Physiol Renal Physiol; 2016 Feb 15; 310(4):F322-33. PubMed ID: 26632605
    [Abstract] [Full Text] [Related]

  • 9. In situ evaluation of podocytes in patients with focal segmental glomerulosclerosis and minimal change disease.
    da Silva CA, Monteiro MLGDR, Araújo LS, Urzedo MG, Rocha LB, Dos Reis MA, Machado JR.
    PLoS One; 2020 Feb 15; 15(11):e0241745. PubMed ID: 33147279
    [Abstract] [Full Text] [Related]

  • 10. Plasma microRNA panel is a novel biomarker for focal segmental glomerulosclerosis and associated with podocyte apoptosis.
    Xiao B, Wang LN, Li W, Gong L, Yu T, Zuo QF, Zhao HW, Zou QM.
    Cell Death Dis; 2018 May 01; 9(5):533. PubMed ID: 29748623
    [Abstract] [Full Text] [Related]

  • 11. Dysregulation of podocyte phenotype in idiopathic collapsing glomerulopathy and HIV-associated nephropathy.
    Yang Y, Gubler MC, Beaufils H.
    Nephron; 2002 Jul 01; 91(3):416-23. PubMed ID: 12119471
    [Abstract] [Full Text] [Related]

  • 12. Patterns of renal involvement in a cohort of patients with inflammatory bowel disease in Egypt.
    Elaziz MMA, Fayed A.
    Acta Gastroenterol Belg; 2018 Jul 01; 81(3):381-385. PubMed ID: 30350525
    [Abstract] [Full Text] [Related]

  • 13. microRNAs in chronic kidney disease.
    Zhao H, Ma SX, Shang YQ, Zhang HQ, Su W.
    Clin Chim Acta; 2019 Apr 01; 491():59-65. PubMed ID: 30639583
    [Abstract] [Full Text] [Related]

  • 14. TRPC6 channel as an emerging determinant of the podocyte injury susceptibility in kidney diseases.
    Ilatovskaya DV, Staruschenko A.
    Am J Physiol Renal Physiol; 2015 Sep 01; 309(5):F393-7. PubMed ID: 26084930
    [Abstract] [Full Text] [Related]

  • 15. Clinical significance of fibroblast-specific protein-1 expression on podocytes in patients with focal segmental glomerulosclerosis.
    Samejima K, Nakatani K, Suzuki D, Asai O, Sakan H, Yoshimoto S, Yamaguchi Y, Matsui M, Akai Y, Toyoda M, Iwano M, Saito Y.
    Nephron Clin Pract; 2012 Sep 01; 120(1):c1-7. PubMed ID: 22126861
    [Abstract] [Full Text] [Related]

  • 16. Circulating and urinary microRNA profile in focal segmental glomerulosclerosis: a pilot study.
    Ramezani A, Devaney JM, Cohen S, Wing MR, Scott R, Knoblach S, Singhal R, Howard L, Kopp JB, Raj DS.
    Eur J Clin Invest; 2015 Apr 01; 45(4):394-404. PubMed ID: 25682967
    [Abstract] [Full Text] [Related]

  • 17. Drug-induced glomerular diseases.
    Garnier AS, Laubacher H, Briet M.
    Therapie; 2024 Apr 01; 79(2):271-281. PubMed ID: 37973491
    [Abstract] [Full Text] [Related]

  • 18. No complement receptor 1 stumps on podocytes in human glomerulopathies.
    Moll S, Miot S, Sadallah S, Gudat F, Mihatsch MJ, Schifferli JA.
    Kidney Int; 2001 Jan 01; 59(1):160-8. PubMed ID: 11135068
    [Abstract] [Full Text] [Related]

  • 19. Ultrastructural features and expression of cytoskeleton proteins of podocyte from patients with minimal change disease and focal segmental glomerulosclerosis.
    Shi SF, Wang SX, Zhang YK, Zhao MH, Zou WZ.
    Ren Fail; 2008 Jan 01; 30(5):477-83. PubMed ID: 18569926
    [Abstract] [Full Text] [Related]

  • 20. Any value of podocyte B7-1 as a biomarker in human MCD and FSGS?
    Novelli R, Gagliardini E, Ruggiero B, Benigni A, Remuzzi G.
    Am J Physiol Renal Physiol; 2016 Mar 01; 310(5):F335-41. PubMed ID: 26697986
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.